(1)
Comparison of Empagliflozin-Linagliptin With Empagliflozin- Metformin Combination Therapy in Assessing Cardiovascular Profile and Anemia in Type 2 Diabetic Patients. J. Bahria Univ. Med. Dent. Coll. 2025, 15 (04), 282-287. https://doi.org/10.51985/JBUMDC2025572.